Now I have all the information I need. Let me write the final consolidated review.

## Summary

This paper introduces the problem of PPI candidate ranking — prioritizing novel interaction candidates for experimental validation — and proposes a two-stage framework. The first stage uses predicted contact maps from D-SCRIPT/Topsy-Turvy to identify "active residues" on known partners, then computes cosine similarity over only those embeddings to rank candidates. The second stage re-ranks the top candidates using diverse biological signals (interaction scores, pDockQ structural scores, functional annotations, LLM-based similarity). Evaluation uses STRING v11 as known interactions and v12 novel interactions as prospective ground truth.

## Strengths

- **Prospective evaluation design (Section 5.1).** Using successive STRING releases (v11 → v12) as a natural temporal split is a genuinely strong experimental choice. It avoids the standard failure of static, same-release benchmarks where test and training sets are drawn from the same distribution, and instead evaluates whether the method can anticipate interactions that were only experimentally confirmed later. This is methodologically sound and clearly the right way to assess prospective value.

- **Interpretability-guided retrieval mechanism (Section 4.1).** Using predicted contact maps to identify "active residues" on known partners and then restricting similarity comparisons to those regions is a creative and principled idea. Rather than using whole-embedding cosine similarity or raw interaction probabilities, the method asks which parts of known partner embeddings are most informative about binding and scores candidates based on those regions. This leverages D-SCRIPT/Topsy-Turvy's internal structure without requiring architectural modifications.

- **Comprehensive re-ranking signal suite (Section 4.2).** The paper systematically tests interaction scores, structural plausibility (pDockQ via SpeedPPI), functional annotations (GO, Pfam, Reactome), token overlap metrics (TF-IDF, Jaccard on localization/key terms), and three LLM-based semantic similarity methods (BioBERT, BioMedRoBERTa, PubMedBERT cross-encoder). This breadth provides a useful picture of which signals are complementary for candidate prioritization.

## Weaknesses

### Major

- **Headline claim is quantitatively overstated (Abstract line 25, Conclusion line 279).** The paper repeatedly claims "improving ranking metrics by two orders of magnitude" (100×). The actual best ratio from Table 1 is ~26× (MAP@5, Recall@5, Precision@5 with D-SCRIPT), and the standard single-number summary MRR shows ~5×. The 26× figure is one order of magnitude, not two. This central quantitative claim — repeated in the abstract, introduction, and conclusion — inflates the apparent contribution. The ~5–26× improvements are still practically meaningful and worth publishing; they should simply be reported honestly.

- **The claimed "integrated two-stage pipeline" is never evaluated as a combined system (Section 4, Section 5.3).** The paper describes a "two-stage framework" (line 73) that "integrates complementary sources of evidence" (abstract). However, the re-ranking results in Table 2 evaluate each signal *independently* — "a new ranking is obtained for each new signal used" (line 109). There is no experiment showing that combining multiple re-ranking signals produces a better final ranking than any single signal. The retrieval stage (Table 1) uses only cosine similarity on activated embeddings; the re-ranking analysis is a set of pairwise rank-shift comparisons between individual signals. The central architectural claim of an integrated pipeline that combines retrieval and multi-signal re-ranking is not tested as a unified system. This is a gap between what the paper claims and what the experiments demonstrate.

### Minor

- **PubMedBERT cross-encoder results likely incorporate training-data leakage (Section 4.2, lines 262–264).** PubMedBERT provides the strongest re-ranking signal (75.5% maintain-or-improve). The authors acknowledge the concern: "it is uncertain if their gains reflect not only semantic generalization but also latent knowledge of interactions from the training data" (lines 262–264). Since PubMedBERT was pre-trained on biomedical literature that may already describe interactions appearing as "novel" in STRING v12, the strong performance may partly reflect leakage rather than genuine prospective generalization. The paper mentions this concern but does not control for it (e.g., by filtering out v12 interactions whose supporting literature predates v11) or clearly label the cross-encoder results as a non-prospective analysis. This does not invalidate the framework but weakens the evidential value of the PubMedBERT-based results as evidence for the re-ranking approach.

- **Missing ablation to isolate the source of improvement (Table 1).** The baselines are raw classification probabilities from D-SCRIPT/Topsy-Turvy, while the proposed method is a specialized retrieval pipeline using embedding similarity with contact-map masking. Without comparing against (a) full-embedding cosine similarity without any masking, or (b) similarity on randomly selected residue windows of the same size, it is unclear whether the gains come from the contact-map guidance specifically or simply from switching from classification scores to any embedding-based retrieval approach. This ablation would directly validate the paper's core methodological claim.

- **No statistical uncertainty reported (Section 5).** All results in Tables 1 and 2 are point estimates without confidence intervals, standard deviations, or significance tests. Since the evaluation uses a single STRING release split (v11→v12), it is not possible to assess whether the reported improvements are stable across different data partitions or reflect idiosyncrasies of this particular transition.

### Trivial

None.

## Nice-to-Haves

- A per-protein breakdown of performance (e.g., stratified by number of known partners) would clarify the method's scope and limitations.
- An error analysis of false positives in the top ranks — are they biologically plausible interactions that simply haven't been confirmed yet?
- Reporting bootstrap confidence intervals for the key retrieval metrics would establish statistical reliability.

## Removed Points

These points are flagged to be removed; treat them with caution:

- **Text formatting artifacts (broken sentences, garbled text at lines 53, 233):** Removed per parser-artifact rule — these are PDF extraction issues, not author errors.
- **Table 2 missing ‡ column in caption:** Removed — incomplete caption text is a parser/stripping artifact.
- **Missing appendix details (hyperparameters, experimental setup):** Removed per rule — appendices are stripped from all submissions.
- **Demands for per-protein breakdown, xCAPT5 retraining details, detailed false-positive analysis:** These are either scope-creep or do not threaten the core claims; they are subsumed under Nice-to-Haves.
- **Criticism that baselines are inherently unfair because they use classification scores:** Baselines are the standard PPI prediction methods; comparing a ranking pipeline against them on a ranking task is legitimate. The real issue (missing ablation) is already captured in the Minor weaknesses.

## Novel Insights

None beyond the paper's own contributions. The reviews confirm the paper's core strengths (prospective STRING split, contact-map-guided retrieval) and pinpoint specific gaps (overstated magnitude, untested pipeline integration) but do not surface a fundamentally new interpretation of the work.

## Suggestions

1. **Correct the "two orders of magnitude" claim** to reflect actual observed ratios (~5–26×). This is the single highest-leverage fix for credibility.
2. **Either run the integrated pipeline** (combining multiple re-ranking signals into a single ranking and evaluating with Table 1 metrics), or adjust the claims to honestly describe the re-ranking analysis as a study of individual signal complementarity rather than an integrated system.
3. **Add the critical ablation** comparing contact-map-guided cosine similarity against full-embedding cosine similarity without masking.
4. **Address the PubMedBERT leakage** transparently — either run a control filtering out v12 interactions with pre-v11 literature support, or explicitly label the cross-encoder results as a non-prospective analysis.
5. **Report confidence intervals** (e.g., bootstrap) for key retrieval metrics.

## MY FINAL SCORE: 5.0

### Reasoning
The paper has a genuinely creative core idea (contact-map-guided embedding retrieval) and a well-designed prospective evaluation using STRING release splits — both are strong contributions. The retrieval results in Table 1 are real and meaningful even with honest framing. However, two structural problems prevent acceptance in the current form. First, the central quantitative claim ("two orders of magnitude") is factually wrong by roughly a factor of 4–20 depending on the metric, and this overstatement appears in the abstract, introduction, and conclusion. Second, the integrated pipeline that forms the paper's architectural contribution is never actually tested as a combined system — the retrieval and re-ranking stages are evaluated independently. These issues are fixable (correction of claims + additional experiments), but as written the gap between claims and evidence is too large. Score 5 reflects a paper with genuine methodological merit that needs substantial revision before it can be accepted.

MY FINAL DECISION: <decision>Reject</decision>